Ultra-test (cyp recalls
The FDA has published 3 recalls involving Ultra-test (cyp since 2017. The latest was reported on 17 Nov 2021. Most were for sterility. Wells Pharmacy Network has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls3since 2017
Last 12 months0reported
Class I00% of total
Ongoing0latest 17 Nov 2021
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 3 100%Class III 0 0%
Why ultra-test (cyp is recalled
Companies
By year
All ultra-test (cyp recalls, newest first
3 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Ultra-test (cyp 80%/prop 20%) 200mg/ML Inj #1 200mg/ML Injectable recalled | Vita Pharmacy | Sterility | DC, PR |
| Drug | CLASS II | Ultra-test (Cyp 80%/Prop 20%) Injectable, 200 mg/mL vial recalled | Wells Pharmacy Network | Sterility | Nationwide |
| Drug | CLASS II | Ultra-test (Cyp 80%/Prop 20%) Injectable, 250 mg/mL vial recalled | Wells Pharmacy Network | Sterility | Nationwide |
Should you stop taking Ultra-test (cyp?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.